CH 45: Drugs for DM Flashcards

1
Q

function of the pancreas

A

secrete glucagon and insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cluster of cells responsible for endocrine function of the pancreas

A

islets of Langerhans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

physiologic action of insulin

A

-promotes entry of glucose into cells
-provides storage of glucose, as glycogen in skeletal muscle and the liver
-inhibits breakdown of fat and glycogen
-increases protein synthesis and inhibits gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hyperglycemic medications:

A

 NSAIDs
 Corticosteroids
 Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hyperglycemic hormones:

A

epi
thyroid
GH
glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hypoglycemic drugs:

A

alcohol
ACE inhibitors
beta blockers
lithium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why can insulin not be given PO

A

GI tract destroys insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

reasons for morning hyperglycemia in patients:

A

-waning insulin
-dawn phenomenon (4-8 am)
-somogyi phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

antihyperglycemic drug used with insulin for DM

A

Pramlintide (Symlin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

labs for regular insulin

A

liver
urinalysis
thyroid
K
Ca
Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

antidiabetic drugs: biguanide (metformin) adverse effects

A

flatulence
D/N
anorexia
abd pain
bitter and metallic taste
lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

antidiabetic drugs: incretin mimetics (GLP-1 agonists) adverse effects

A

N/V/D
nervousness
injection site reactions
antibody formation
pancreatitis
CKD
thyroid tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

antidiabetic drugs: Incretin enhancers (DPP-4 inhibitors) adverse effects

A

flulike symptoms
URI
back pain
hypoglycemia
hepatic impairment
anaphylaxis
pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

antidiabetic drugs: Meglitinides adverse effects

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

antidiabetic drugs: sulfonylureas adverse effects

A

N
heartburn
dizziness
HA
drowsiness
hypoglycemia
cholestatic jaundice
blood dyscasias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

antidiabetic drugs: thiazolidinediones adverse effects

A

URI
myalgia
HA
edema
weight gain
hypoglycemia
cholestatic jaundice
blood dyscrasias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

antidiabetic drugs: other possible adverse effects

A

confusion
agitation
hallucinations
female genital infections
UTI
nasopharyngitis
hypotension
CKD
hyperkalemia
hypoglycemia

18
Q

Metformin (Biguanide) therapuetic effects

A

treatment of type 2 DM

19
Q

Metformin (Biguanide) adverse effects

A

N/V/D
abd discomfort
metallic taste
anorexia
HA
dizziness
agitation
fatigue

20
Q

Metformin (Biguanide) labs

A

false positive urinary ketones

21
Q

Metformin (Biguanide) onset, peak, duration

A

onset = less than 1 hr
peak = 1-3 hr
duration = 12 -24 hr

22
Q

MOA for thiazolidinediones

A

reduce blood glucose by decreasing insulin resistance and inhibiting hepatic gluconeogenesis

23
Q

MOA of meglitinides

A

act by stimulating the release of insulin form pancreatic islet cells

24
Q

MOA of incretion mimetics

A

activate receptor GLP-1 causing lower blood glucose by increasing secretion of insulin slowing absorption of glucose and reducing glucagon

25
Q

MOA of incretion enhancers

A

allow naturla incretion levels to rise and produce greater response by lowering blood glucose

26
Q

administration and compatibility of insulin lispro

A

subq - 5-10 min before meals
can give with NPH - draw lispro first

27
Q

administration and compatibility of regular insulin

A

subq - 30-60 m before meals - IV
can mix with NPH, sterile water or normal saline

28
Q

administration and compatibility of NPH

A

subq - 30 min before first meal
can mix with aspart, lispro, regular

29
Q

admin of insulin glargine

A

subq - once daily

30
Q

insulin therapy goal is a1c below

A

6.5%

31
Q

glucose between meals

A

Pancreas secretes glucagon = the opposite effect of insulin = glucose rises

32
Q

body’s reaction to hyperglycemia

A

pancreas secretes insulin
cells take up glucose for energy and storage
homeostasis restored

33
Q

body’s reaction to hypoglycemia

A

pancreas secretes glucagon
liver breaks down glycogen, returning glucose to blood
homeostasis restored

34
Q

body’s reaction to hypoglycemia

A

pancreas secretes glucagon
liver breaks down glycogen, returning glucose to blood
homeostasis restored

35
Q

S/S of hypoglycemia

A

pale
cool
moist skin
confusion
lightheaded
weak
anxious

36
Q

biguanide (metformin) safety and monitoring

A

GI distress, metallic taste, diarrhea, anorexia
Kidney function
d/c 2 days prior and 2 days after IV contrast
lactic acidosis
vitamins B12, folic acid levels
Report drowsiness, malaise, general body aches

37
Q

GLP 1 Agonists safety and monitoring

A

Gi symptoms
Pancreatitis
Renal insufficiency
hypoglycemia

38
Q

DPP 4 Inhibitors (Onglyza) safety and monitoring

A

Pancreatitis
hypersensitivity

39
Q

Meglintinidines (prandin) safety

A

hypoglycemia
weight gain
take with first bite of meal

40
Q

sulfonylureas (glyburide) safety and monitoring

A

Weight gain
Liver dysfunction
Hypoglycemia
Avoid alcohol

41
Q

thiazolidinediones (actos) safety and monitoring

A

May require 3 to 4 months to work
Liver function
Hypoglycemia
Fractures in women
Unintended pregancy Black box for heart failure
hypoglycemia